remdesivir for Covid-19,

Two-Thirds of Severe Covid-19 Cases Improved ... - Bloomberg

https://www.bloomberg.com › news › articles › two-thirds-of-severe-covid...

3 days ago - Several large scale clinical trials are underway to evaluate the benefit of remdesivir for Covid-19, the disease caused by the novel coronavirus ...

NIH clinical trial of remdesivir to treat COVID-19 begins ...

https://www.nih.gov › news-events › news-releases › nih-clinical-trial-rem...

Feb 25, 2020 - There have been 14 confirmed COVID-19 cases reported in the United States and an additional 39 cases among persons repatriated to the ...

COVID-19 Daily: Remdesivir Data Published, World Leader ...

https://www.medscape.com › viewarticle

16 hours ago - COVID-19 Daily: Early Remdesivir Data Published, World Leader ... for persistent symptoms of COVID-19 and spent 3 days in intensive care, ...

Two-Thirds of Severe Covid-19 Cases Improved on Gilead Drug

https://www.bloombergquint.com › coronavirus-outbreak › two-thirds-of-s...

3 days ago - Several large scale clinical trials are underway to evaluate the benefit of remdesivir for Covid-19, the disease caused by the novel coronavirus ...

Patients rush to join testing of Covid-19 drug remdesivir ...

https://www.indiatoday.in › World

Apr 6, 2020 - Patients rush to join testing of Covid-19 drug remdesivir ... about life support while wheeling him into Massachusetts General's intensive care unit. ... Gilead has given remdesivir to more than 1,700 patients on a case-by-case ...

Did an experimental drug help a U.S. coronavirus patient ...

https://www.sciencemag.org › news › 2020/03 › did-experimental-drug-he...

Mar 13, 2020 - Click here for free access to our latest coronavirus/COVID-19 research, ... that a critically ill patient it had been treating for a week had coronavirus ... States to an infected area or been in known contact with a confirmed case. ... The drug, remdesivir made by Gilead Sciences, is given by an intravenous drip.

Gilead halts emergency access to COVID-19 contender ...

https://www.fiercepharma.com › pharma › gilead-halts-emergency-access-t...

Mar 23, 2020 - The spike of COVID-19 cases in Europe and the U.S. “flooded an ... is the primary way to access remdesivir to generate critical data that inform ...

Gilead suspends access to experimental Covid-19 drug ... - Stat

https://www.statnews.com › 2020/03/22 › gilead-suspends-access-to-experi...

Mar 22, 2020 - The company said “enrollment in clinical trials is the primary way to access remdesivir to generate critical data" on appropriate use of the drug.

PulmCrit Wee- Could the best mode of noninvasive support for ...

https://emcrit.org › pulmcrit › cpap-covid

Mar 17, 2020 - Using excessively high pressure could risk gastric insufflation and aspiration ... This is particularly critical for patients with COVID-19, who may ...

Form 8-K VAPOTHERM INC For: Apr 13 - StreetInsider.com

https://www.streetinsider.com › news

3 hours ago - The spread of COVID-19 has resulted in certain disruptions to our business and ... suppliers, is at risk– if a critical threshold of our personnel, or the personnel of ... Current demand necessitates weekly and, in some cases, daily ... and mouth while delivering high velocity nasal insufflation, could prove to be ...